바이오리액터 시장(2022-2027년) : 세계 산업 동향, 점유율, 규모, 성장, 기회, 예측

The global bioreactor market reached a value of US$ 5.64 Billion in 2021. Looking forward, IMARC Group expects the market to reach a value of US$ 11.84 Billion by 2027, exhibiting a CAGR of 12.50% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.

A bioreactor refers to a fermentation vessel, wherein biological reactions are executed for developing enzymes and various organisms, including bacteria, animal cells and yeast, under controlled conditions. It aids in producing several pharmaceuticals, such as vaccines and monoclonal antibodies, maintaining the inhomogeneous state of the cells to obtain the desired output, and monitoring the environmental conditions for promoting the cell formation process. On account of these properties, a bioreactor is extensively used by biopharmaceutical companies, research and development (R&D) institutions, and contract research organizations (CROs). At present, it is commercially available in glass, stainless steel, and single-use material types.

Bioreactor Market Trends:

The global bioreactor market is majorly driven by the increasing prevalence of various chronic diseases, such as cancer and diabetes, especially amongst the steadily rising geriatric population. In line with this, the growing need for preventive vaccines, particularly during the sudden outbreak of the coronavirus disease (COVID-19) pandemic, have prompted several pharmaceutical companies to considerably invest in research and development (R&D) activities to extend their production capacities. This, in turn, is inflating the overall sales of bioreactors across the globe. Additionally, significant technological advancements, such as the introduction of single-use bioreactors (SUBs) for optimizing the quality, flexibility, and scalability of microorganisms' formation operations with minimal cost and energy requirements, are positively stimulating the market growth. Apart from this, increasing biopharmaceuticals manufacturing capacities across developing nations, along with the rising demand for bioreactors that support modern, evolving, high-cell density, and intensified clinical processes requiring high oxygen transfer and great carbon dioxide (CO2) removal are propelling the market growth. Other factors, such as rapid expansion in the pharmaceutical and biologics sectors, the escalating need for effective treatment drugs, and the increasing awareness among consumers regarding the formulation and availability of personalized medicines, are contributing to the market growth significantly.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global bioreactor market, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on type, usage, scale and control type.

Breakup by Type:

• Glass
• Stainless Steel
• Single-Use

Breakup by Usage:

• Lab-Scale Production
• Pilot-Scale Production
• Full-Scale Production

Breakup by Scale:

• 5L-20L
• 20L-200L
• 200L-1500L
• Above 1500L

Breakup by Control Type:

• Manual
• Automated

Breakup by Region:

• North America
  • United States
  • Canada

• Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others

• Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others

• Latin America
  • Brazil
  • Mexico
  • Others

• Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being 2mag AG, bbi-biotech GmbH, Bioengineering AG, Eppendorf SE, Getinge AB, Infors AG, Merck KGaA, Pall Corporation (Danaher Corporation), Sartorius AG, Solaris Biotechnology Srl and Thermo Fisher Scientific Inc.

Key Questions Answered in This Report:

• How has the global bioreactor market performed so far and how will it perform in the coming years?

• What has been the impact of COVID-19 on the global bioreactor market?

• What are the key regional markets?

• What is the breakup of the market based on the type?

• What is the breakup of the market based on the usage?

• What is the breakup of the market based on the scale?

• What is the breakup of the market based on the control type?

• What are the various stages in the value chain of the industry?

• What are the key driving factors and challenges in the industry?

• What is the structure of the global bioreactor market and who are the key players?

• What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Bioreactor Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Type

• 6.1 Glass
  • 6.1.1 Market Trends
  • 6.1.2 Market Forecast
• 6.2 Stainless Steel
  • 6.2.1 Market Trends
  • 6.2.2 Market Forecast
• 6.3 Single-Use
  • 6.3.1 Market Trends
  • 6.3.2 Market Forecast

7 Market Breakup by Usage

• 7.1 Lab-Scale Production
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Pilot-Scale Production
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast
• 7.3 Full-Scale Production
  • 7.3.1 Market Trends
  • 7.3.2 Market Forecast

8 Market Breakup by Scale

• 8.1 5L-20L
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
• 8.2 20L-200L
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast
• 8.3 200L-1500L
  • 8.3.1 Market Trends
  • 8.3.2 Market Forecast
• 8.4 Above 1500L
  • 8.4.1 Market Trends
  • 8.4.2 Market Forecast

9 Market Breakup by Control Type

• 9.1 Manual
  • 9.1.1 Market Trends
  • 9.1.2 Market Forecast
• 9.2 Automated
  • 9.2.1 Market Trends
  • 9.2.2 Market Forecast

10 Market Breakup by Region

• 10.1 North America
  • 10.1.1 United States
    • 10.1.1.1 Market Trends
    • 10.1.1.2 Market Forecast
  • 10.1.2 Canada
    • 10.1.2.1 Market Trends
    • 10.1.2.2 Market Forecast
• 10.2 Asia-Pacific
  • 10.2.1 China
    • 10.2.1.1 Market Trends
    • 10.2.1.2 Market Forecast
  • 10.2.2 Japan
    • 10.2.2.1 Market Trends
    • 10.2.2.2 Market Forecast
  • 10.2.3 India
    • 10.2.3.1 Market Trends
    • 10.2.3.2 Market Forecast
  • 10.2.4 South Korea
    • 10.2.4.1 Market Trends
    • 10.2.4.2 Market Forecast
  • 10.2.5 Australia
    • 10.2.5.1 Market Trends
    • 10.2.5.2 Market Forecast
  • 10.2.6 Indonesia
    • 10.2.6.1 Market Trends
    • 10.2.6.2 Market Forecast
  • 10.2.7 Others
    • 10.2.7.1 Market Trends
    • 10.2.7.2 Market Forecast
• 10.3 Europe
  • 10.3.1 Germany
    • 10.3.1.1 Market Trends
    • 10.3.1.2 Market Forecast
  • 10.3.2 France
    • 10.3.2.1 Market Trends
    • 10.3.2.2 Market Forecast
  • 10.3.3 United Kingdom
    • 10.3.3.1 Market Trends
    • 10.3.3.2 Market Forecast
  • 10.3.4 Italy
    • 10.3.4.1 Market Trends
    • 10.3.4.2 Market Forecast
  • 10.3.5 Spain
    • 10.3.5.1 Market Trends
    • 10.3.5.2 Market Forecast
  • 10.3.6 Russia
    • 10.3.6.1 Market Trends
    • 10.3.6.2 Market Forecast
  • 10.3.7 Others
    • 10.3.7.1 Market Trends
    • 10.3.7.2 Market Forecast
• 10.4 Latin America
  • 10.4.1 Brazil
    • 10.4.1.1 Market Trends
    • 10.4.1.2 Market Forecast
  • 10.4.2 Mexico
    • 10.4.2.1 Market Trends
    • 10.4.2.2 Market Forecast
  • 10.4.3 Others
    • 10.4.3.1 Market Trends
    • 10.4.3.2 Market Forecast
• 10.5 Middle East and Africa
  • 10.5.1 Market Trends
  • 10.5.2 Market Breakup by Country
  • 10.5.3 Market Forecast

11 SWOT Analysis

• 11.1 Overview
• 11.2 Strengths
• 11.3 Weaknesses
• 11.4 Opportunities
• 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

• 13.1 Overview
• 13.2 Bargaining Power of Buyers
• 13.3 Bargaining Power of Suppliers
• 13.4 Degree of Competition
• 13.5 Threat of New Entrants
• 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

• 15.1 Market Structure
• 15.2 Key Players
• 15.3 Profiles of Key Players
  • 15.3.1 2mag AG
    • 15.3.1.1 Company Overview
    • 15.3.1.2 Product Portfolio
  • 15.3.2 bbi-biotech GmbH
    • 15.3.2.1 Company Overview
    • 15.3.2.2 Product Portfolio
  • 15.3.3 Bioengineering AG
    • 15.3.3.1 Company Overview
    • 15.3.3.2 Product Portfolio
  • 15.3.4 Eppendorf SE
    • 15.3.4.1 Company Overview
    • 15.3.4.2 Product Portfolio
    • 15.3.4.3 Financials
    • 15.3.4.4 SWOT Analysis
  • 15.3.5 Getinge AB
    • 15.3.5.1 Company Overview
    • 15.3.5.2 Product Portfolio
    • 15.3.5.3 Financials
    • 15.3.5.4 SWOT Analysis
  • 15.3.6 Infors AG
    • 15.3.6.1 Company Overview
    • 15.3.6.2 Product Portfolio
  • 15.3.7 Merck KGaA
    • 15.3.7.1 Company Overview
    • 15.3.7.2 Product Portfolio
    • 15.3.7.3 Financials
    • 15.3.7.4 SWOT Analysis
  • 15.3.8 Pall Corporation (Danaher Corporation)
    • 15.3.8.1 Company Overview
    • 15.3.8.2 Product Portfolio
    • 15.3.8.3 Financials
  • 15.3.9 Sartorius AG
    • 15.3.9.1 Company Overview
    • 15.3.9.2 Product Portfolio
    • 15.3.9.3 Financials
    • 15.3.9.4 SWOT Analysis
  • 15.3.10 Solaris Biotechnology Srl
    • 15.3.10.1 Company Overview
    • 15.3.10.2 Product Portfolio
  • 15.3.11 Thermo Fisher Scientific Inc.
    • 15.3.11.1 Company Overview
    • 15.3.11.2 Product Portfolio
    • 15.3.11.3 Financials
    • 15.3.11.4 SWOT Analysis